Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence01:27

Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence

34
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
34
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism01:21

Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism

440
Polymorphism refers to the existence of a drug substance in multiple crystalline forms, known as polymorphs. Recently, this term has been expanded to include solvates (forms containing a solvent), amorphous forms (non-crystalline forms), and desolvated solvates (forms from which the solvent has been removed).
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
440

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A user's guide to your first self-driving liquid handling lab.

Digital discovery·2026
Same author

Automation-Assisted Photoinduced Atom Transfer Radical Polymerization.

ACS polymers Au·2026
Same author

Gene Delivery Mediated by Backbone-Degradable RAFT Copolymers.

Biomacromolecules·2026
Same author

Automated active learning to optimize hydrogel drug release profiles.

Journal of controlled release : official journal of the Controlled Release Society·2026
Same author

Gene Delivery Mediated by Backbone-Degradable RAFT Copolymers.

bioRxiv : the preprint server for biology·2025
Same author

SAXS Assistant: Automated SAXS analysis for structural discovery in biologics and polymeric nanoparticles.

Biophysical journal·2025
Same journal

Miscibility and Cocrystallization in Ethylene-Vinyl Alcohol Copolymer Blends.

ACS applied polymer materials·2026
Same journal

Is Recycled Polypropylene Suitable for Flame-Retarded Applications?

ACS applied polymer materials·2026
Same journal

Antimicrobial Coating of Surgical Meshes by Laser-Induced Nanocarbon Synthesis and Transfer.

ACS applied polymer materials·2026
Same journal

Effect of Dialysis on the Osmotic Pressure, Conductivity, and Rheology of Aqueous Polyelectrolyte Solutions.

ACS applied polymer materials·2026
Same journal

Design of a Chitinase-Responsive, Depolymerizable Petroleum-Derived Polymer for Circular and Antifouling Materials.

ACS applied polymer materials·2026
Same journal

Hydrogen Valorization from Industrial Waste Streams Using Matrimid/LaNi<sub>5</sub> Mixed Matrix Hollow Fiber Membranes.

ACS applied polymer materials·2026
See all related articles

Related Experiment Video

Updated: Oct 25, 2025

High-throughput Synthesis of Carbohydrates and Functionalization of Polyanhydride Nanoparticles
14:37

High-throughput Synthesis of Carbohydrates and Functionalization of Polyanhydride Nanoparticles

Published on: July 6, 2012

11.6K

Automated PET-RAFT Polymerization Towards Pharmaceutical Amorphous Solid Dispersion Development.

Rahul Upadhya1, Ashish Punia2, Mythili J Kanagala1

  • 1Department of Biomedical Engineering, Rutgers, The State University of New Jersey, Piscataway, NJ 08854, USA.

ACS Applied Polymer Materials
|August 9, 2021
PubMed
Summary
This summary is machine-generated.

Developing new polymers for amorphous solid dispersions (ASDs) improves oral drug bioavailability. This study used a combinatorial approach to create and screen novel polymer excipients, identifying key relationships for better drug delivery systems.

Keywords:
amorphous solid dispersionscombinatorial polymer synthesisdrug precipitation inhibitionoral drug deliverypolymer excipients

More Related Videos

Synthesis of Monodisperse Cylindrical Nanoparticles via Crystallization-driven Self-assembly of Biodegradable Block Copolymers
11:42

Synthesis of Monodisperse Cylindrical Nanoparticles via Crystallization-driven Self-assembly of Biodegradable Block Copolymers

Published on: June 20, 2019

8.0K
Facile Synthesis of Worm-like Micelles by Visible Light Mediated Dispersion Polymerization Using Photoredox Catalyst
07:39

Facile Synthesis of Worm-like Micelles by Visible Light Mediated Dispersion Polymerization Using Photoredox Catalyst

Published on: June 8, 2016

9.7K

Related Experiment Videos

Last Updated: Oct 25, 2025

High-throughput Synthesis of Carbohydrates and Functionalization of Polyanhydride Nanoparticles
14:37

High-throughput Synthesis of Carbohydrates and Functionalization of Polyanhydride Nanoparticles

Published on: July 6, 2012

11.6K
Synthesis of Monodisperse Cylindrical Nanoparticles via Crystallization-driven Self-assembly of Biodegradable Block Copolymers
11:42

Synthesis of Monodisperse Cylindrical Nanoparticles via Crystallization-driven Self-assembly of Biodegradable Block Copolymers

Published on: June 20, 2019

8.0K
Facile Synthesis of Worm-like Micelles by Visible Light Mediated Dispersion Polymerization Using Photoredox Catalyst
07:39

Facile Synthesis of Worm-like Micelles by Visible Light Mediated Dispersion Polymerization Using Photoredox Catalyst

Published on: June 8, 2016

9.7K

Area of Science:

  • Pharmaceutical Sciences
  • Materials Science
  • Polymer Chemistry

Background:

  • Over 90% of pharmaceutical drugs in development exhibit poor aqueous solubility, hindering oral bioavailability.
  • Amorphous solid dispersions (ASDs) are a key strategy to enhance oral bioavailability of poorly soluble active pharmaceutical ingredients (APIs).
  • Limited regulatory-approved polymer excipients necessitate the design of novel materials for tailored ASD development.

Purpose of the Study:

  • To explore an automated combinatorial library approach for synthesizing and screening polymer excipients for amorphous solid dispersions (ASDs).
  • To investigate the relationship between polymer characteristics and the dissolution performance of a model drug, probucol.
  • To identify novel polymer excipients that can effectively enhance oral drug delivery.

Main Methods:

  • Synthesis of a 25-member random heteropolymer library with varying ratios of hydrophilic (2-hydroxypropyl acrylate) and hydrophobic monomers.
  • Fabrication of ASDs using a rapid film casting method.
  • Evaluation of ASD performance via dissolution testing with ultra-performance liquid chromatography (UPLC) analysis.

Main Results:

  • A clear correlation was established between polymer hydrophobicity, monomer side group geometry, and the dissolution performance of probucol.
  • Novel synthesized polymers demonstrated effective enhancement of drug dissolution compared to existing standards.
  • The most effective polymers exhibited modulated drug release kinetics, offering potential for controlled drug delivery.

Conclusions:

  • An automated combinatorial library approach is effective for rapid synthesis and screening of polymer excipients for ASDs.
  • Understanding polymer-API interactions is crucial for designing effective drug delivery systems.
  • This strategy enables the identification of designer polymer excipients with tunable properties for specific API functionalities and improved oral bioavailability.